Literature DB >> 30284668

1H, 15N, and 13C resonance assignments of the intrinsically disordered SH4 and Unique domains of Hck.

Matthew P Pond1, Lydia Blachowicz2, Benoît Roux3.   

Abstract

Hematopoietic cell kinase (Hck) is an important signaling enzyme and a potential drug target for HIV infections and Bcr/Abl-chronic myeloid leukemia. The protein shares the same SH4-Unique-SH3-SH2-kinase multi-domain architecture as the other eight members of the Src family of non-receptor tyrosine kinases. These enzymes are often found anchored to the intracellular side of the membrane via lipidation of the SH4 domain and are integral components of signaling cascades localized at the cell surface. Despite the detailed structural information available for the SH3, SH2, and kinase domains of Hck, the intrinsically disordered nature of the SH4 and Unique domains has resulted in a lack of information for this important region of the protein that is responsible for membrane association. Here, we report the 1H, 15N and 13C chemical shifts of the Hck SH4-Unique domains at pH 4.5.

Entities:  

Keywords:  Hck; Intrinsically disordered protein; Src family kinase

Mesh:

Substances:

Year:  2018        PMID: 30284668      PMCID: PMC6440858          DOI: 10.1007/s12104-018-9854-z

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  9 in total

1.  Removal of a time barrier for high-resolution multidimensional NMR spectroscopy.

Authors:  Victor Jaravine; Ilgis Ibraghimov; Vladislav Yu Orekhov
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

2.  The SH3 Domain Acts as a Scaffold for the N-Terminal Intrinsically Disordered Regions of c-Src.

Authors:  Mariano Maffei; Miguel Arbesú; Anabel-Lise Le Roux; Irene Amata; Serge Roche; Miquel Pons
Journal:  Structure       Date:  2015-04-23       Impact factor: 5.006

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 4.  Myristylation and palmitylation of Src family members: the fats of the matter.

Authors:  M D Resh
Journal:  Cell       Date:  1994-02-11       Impact factor: 41.582

5.  Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.

Authors:  Joseph A Marsh; Vinay K Singh; Zongchao Jia; Julie D Forman-Kay
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

6.  A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8.

Authors:  Peter W Kim; Zhen-Yu J Sun; Stephen C Blacklow; Gerhard Wagner; Michael J Eck
Journal:  Science       Date:  2003-09-19       Impact factor: 47.728

Review 7.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

8.  Probabilistic interaction network of evidence algorithm and its application to complete labeling of peak lists from protein NMR spectroscopy.

Authors:  Arash Bahrami; Amir H Assadi; John L Markley; Hamid R Eghbalnia
Journal:  PLoS Comput Biol       Date:  2009-03-13       Impact factor: 4.475

Review 9.  Phosphorylation of unique domains of Src family kinases.

Authors:  Irene Amata; Mariano Maffei; Miquel Pons
Journal:  Front Genet       Date:  2014-06-30       Impact factor: 4.599

  9 in total
  2 in total

1.  Membrane Anchoring of Hck Kinase via the Intrinsically Disordered SH4-U and Length Scale Associated with Subcellular Localization.

Authors:  Matthew P Pond; Rebecca Eells; Bradley W Treece; Frank Heinrich; Mathias Lösche; Benoît Roux
Journal:  J Mol Biol       Date:  2019-12-23       Impact factor: 5.469

Review 2.  Dynamic regulatory features of the protein tyrosine kinases.

Authors:  Neha Amatya; David Yin-Wei Lin; Amy H Andreotti
Journal:  Biochem Soc Trans       Date:  2019-08-08       Impact factor: 5.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.